{"id":"https://openalex.org/W2889873077","doi":"https://doi.org/10.1200/jco.2017.35.15_suppl.5071","title":"Phase 1-2 study of progesterone receptor (PR) inhibition with extended-release (ER) onapristone (ONA) alone or in combination with abiraterone (AA) in patients (pts) with castration-resistant prostate cancer (CRPC) incorporating plasma DNA analysis to define androgen receptor (AR) status.","display_name":"Phase 1-2 study of progesterone receptor (PR) inhibition with extended-release (ER) onapristone (ONA) alone or in combination with abiraterone (AA) in patients (pts) with castration-resistant prostate cancer (CRPC) incorporating plasma DNA analysis to define androgen receptor (AR) status.","publication_year":2017,"publication_date":"2017-05-20","ids":{"openalex":"https://openalex.org/W2889873077","doi":"https://doi.org/10.1200/jco.2017.35.15_suppl.5071","mag":"2889873077"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2017.35.15_suppl.5071","doi":"https://doi.org/10.1200/jco.2017.35.15_suppl.5071","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2017.35.15_suppl.5071","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008796630","display_name":"Anuradha Jayaram","orcid":"https://orcid.org/0000-0002-5255-8909","observed_orcids":["https://orcid.org/0000-0002-5255-8909"]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Anuradha Jayaram","raw_affiliation_strings":["Institute of Cancer Research and The Royal Marsden NHS Trust Foundation, Sutton, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Cancer Research and The Royal Marsden NHS Trust Foundation, Sutton, United Kingdom;","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056862447","display_name":"Karolina Nowakowska","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Karolina Nowakowska","raw_affiliation_strings":["The Institue of Cancer Research, The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Institue of Cancer Research, The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom;","institution_ids":["https://openalex.org/I1325846038"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037380661","display_name":"Joaqu\u0131\u0301n Mateo","orcid":"https://orcid.org/0000-0001-5336-2548","observed_orcids":["https://orcid.org/0000-0001-5336-2548"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Joaquin Mateo","raw_affiliation_strings":["The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom;","institution_ids":["https://openalex.org/I142947616","https://openalex.org/I4210121186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048376633","display_name":"Sanjeev Srinivas Kumar","orcid":"https://orcid.org/0000-0001-6017-1117","observed_orcids":["https://orcid.org/0000-0001-6017-1117"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sanjeev Kumar","raw_affiliation_strings":["Cambridge University Hospitals, Cambridge, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cambridge University Hospitals, Cambridge, United Kingdom;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109473631","display_name":"Tatiana Hern\u00e1ndez","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tatiana Hernandez","raw_affiliation_strings":["Cambridge University Hospitals, Cambridge, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cambridge University Hospitals, Cambridge, United Kingdom;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043151436","display_name":"Ben Fulton","orcid":"https://orcid.org/0000-0003-3531-0888","observed_orcids":["https://orcid.org/0000-0003-3531-0888"]},"institutions":[{"id":"https://openalex.org/I7882870","display_name":"University of Glasgow","ror":"https://ror.org/00vtgdb53","country_code":"GB","type":"education","lineage":["https://openalex.org/I7882870"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Ben Fulton","raw_affiliation_strings":["Institute of Cancer Sciences, Glasgow, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Cancer Sciences, Glasgow, United Kingdom;","institution_ids":["https://openalex.org/I7882870"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078001213","display_name":"Daniel Nava Rodrigues","orcid":"https://orcid.org/0000-0003-0220-3146","observed_orcids":["https://orcid.org/0000-0003-0220-3146","https://orcid.org/0009-0003-9872-1008"]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Daniel Nava Rodrigues","raw_affiliation_strings":["The Institue of Cancer Research, The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Institue of Cancer Research, The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom;","institution_ids":["https://openalex.org/I1325846038"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066136399","display_name":"Ruth Riisnaes","orcid":"https://orcid.org/0000-0002-8924-302X","observed_orcids":["https://orcid.org/0000-0002-8924-302X"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Ruth Riisnaes","raw_affiliation_strings":["Cancer Biomarkers Laboratory, The Institute of Cancer Research, London, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Biomarkers Laboratory, The Institute of Cancer Research, London, United Kingdom;","institution_ids":["https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112385376","display_name":"Alexander A. Zukiwski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210089929","display_name":"Arno Therapeutics (United States)","ror":"https://ror.org/00apva622","country_code":"US","type":"company","lineage":["https://openalex.org/I4210089929"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexander Zukiwski","raw_affiliation_strings":["Arno Therapeutics, Inc., Flemington, NJ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Arno Therapeutics, Inc., Flemington, NJ;","institution_ids":["https://openalex.org/I4210089929"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069069870","display_name":"Alice Susannah Bexon","orcid":"https://orcid.org/0009-0005-1931-1153","observed_orcids":["https://orcid.org/0009-0005-1931-1153"]},"institutions":[{"id":"https://openalex.org/I4210142945","display_name":"Bexon Clinical Consulting (United States)","ror":"https://ror.org/053rz5s61","country_code":"US","type":"company","lineage":["https://openalex.org/I4210142945"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alice Susannah Bexon","raw_affiliation_strings":["Bexon Clinical Consulting, Montclair, NJ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bexon Clinical Consulting, Montclair, NJ;","institution_ids":["https://openalex.org/I4210142945"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034474315","display_name":"Stefan Proniuk","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210089929","display_name":"Arno Therapeutics (United States)","ror":"https://ror.org/00apva622","country_code":"US","type":"company","lineage":["https://openalex.org/I4210089929"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stefan Proniuk","raw_affiliation_strings":["Arno Therapeutics, Inc., Flemington, NJ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Arno Therapeutics, Inc., Flemington, NJ;","institution_ids":["https://openalex.org/I4210089929"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089192512","display_name":"Charles P. Barranco","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210089929","display_name":"Arno Therapeutics (United States)","ror":"https://ror.org/00apva622","country_code":"US","type":"company","lineage":["https://openalex.org/I4210089929"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charles Barranco","raw_affiliation_strings":["Arno Therapeutics, Inc., Flemington, NJ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Arno Therapeutics, Inc., Flemington, NJ;","institution_ids":["https://openalex.org/I4210089929"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088696108","display_name":"Diletta Bianchini","orcid":"https://orcid.org/0009-0002-5071-7301","observed_orcids":["https://orcid.org/0009-0002-5071-7301"]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Diletta Bianchini","raw_affiliation_strings":["The Institue of Cancer Research, The Royal Marsden NHS Foundation Trust, London, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Institue of Cancer Research, The Royal Marsden NHS Foundation Trust, London, United Kingdom;","institution_ids":["https://openalex.org/I1325846038"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089083095","display_name":"Zafeiris Zafeirou","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Zafeiris Zafeirou","raw_affiliation_strings":["The Institue of Cancer Research, The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Institue of Cancer Research, The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom;","institution_ids":["https://openalex.org/I1325846038"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103501093","display_name":"Raquel P\u00e9rez L\u00f3pez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Raquel Perez Lopez","raw_affiliation_strings":["The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom;","institution_ids":["https://openalex.org/I142947616","https://openalex.org/I4210121186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056339622","display_name":"Nina Tunariu","orcid":"https://orcid.org/0000-0001-6656-3699","observed_orcids":["https://orcid.org/0000-0001-6656-3699"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Nina Tunariu","raw_affiliation_strings":["The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom;","institution_ids":["https://openalex.org/I142947616","https://openalex.org/I4210121186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018384442","display_name":"Simon Pacey","orcid":"https://orcid.org/0000-0002-3303-7577","observed_orcids":["https://orcid.org/0000-0002-3303-7577"]},"institutions":[{"id":"https://openalex.org/I241749","display_name":"University of Cambridge","ror":"https://ror.org/013meh722","country_code":"GB","type":"education","lineage":["https://openalex.org/I241749"]},{"id":"https://openalex.org/I4210156194","display_name":"Addenbrooke's Hospital","ror":"https://ror.org/055vbxf86","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802466933","https://openalex.org/I4210156194"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Simon Pacey","raw_affiliation_strings":["The University of Cambridge, Addenbrookes Hospital, Cambridge, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Cambridge, Addenbrookes Hospital, Cambridge, United Kingdom;","institution_ids":["https://openalex.org/I241749","https://openalex.org/I4210156194"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048796030","display_name":"Robert J. Jones","orcid":"https://orcid.org/0000-0002-2904-6980","observed_orcids":["https://orcid.org/0000-0002-2904-6980","https://orcid.org/0000-0003-0759-8968"]},"institutions":[{"id":"https://openalex.org/I2800373718","display_name":"Beatson West of Scotland Cancer Centre","ror":"https://ror.org/03pp86w19","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800373718"]},{"id":"https://openalex.org/I7882870","display_name":"University of Glasgow","ror":"https://ror.org/00vtgdb53","country_code":"GB","type":"education","lineage":["https://openalex.org/I7882870"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Robert J. Jones","raw_affiliation_strings":["University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom;","institution_ids":["https://openalex.org/I2800373718","https://openalex.org/I7882870"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072378199","display_name":"Johann Sebastian De Bono","orcid":"https://orcid.org/0000-0002-2034-595X","observed_orcids":["https://orcid.org/0000-0002-2034-595X"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Johann S. De Bono","raw_affiliation_strings":["The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom;","institution_ids":["https://openalex.org/I142947616","https://openalex.org/I4210121186"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5000156180","display_name":"Gerhardt Attard","orcid":"https://orcid.org/0000-0002-4811-7983","observed_orcids":["https://orcid.org/0000-0002-4811-7983"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Gerhardt Attard","raw_affiliation_strings":["The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, United Kingdom;","institution_ids":["https://openalex.org/I142947616","https://openalex.org/I4210121186"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":9,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"35","issue":"15_suppl","first_page":"5071","last_page":"5071"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/onapristone","display_name":"onapristone","score":0.847000002861023},{"id":"https://openalex.org/keywords/castration-resistant-prostate-cancer","display_name":"castration-resistant prostate cancer","score":0.9330000281333923},{"id":"https://openalex.org/keywords/abiraterone-acetate","display_name":"abiraterone","score":0.949999988079071},{"id":"https://openalex.org/keywords/androgen-receptor-mutations","display_name":"androgen receptor mutations","score":0.7350000143051147},{"id":"https://openalex.org/keywords/enzalutamide-resistance","display_name":"enzalutamide resistance","score":0.800000011920929},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.6330000162124634},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.460999995470047},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7549999952316284},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.45899999141693115},{"id":"https://openalex.org/keywords/psa-response","display_name":"PSA response","score":0.47699999809265137},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.3330000042915344},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.3019999861717224}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8515332341194153},{"id":"https://openalex.org/C2776551883","wikidata":"https://www.wikidata.org/wiki/Q1996756","display_name":"Enzalutamide","level":5,"score":0.7450597882270813},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.6095722913742065},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5654508471488953},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5262647867202759},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.4881230294704437},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.4741869866847992},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4487645626068115},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.4445379376411438},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4148731529712677},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4057276248931885},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.33971190452575684},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.33616527915000916},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3287718594074249},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.32581818103790283},{"id":"https://openalex.org/C61367390","wikidata":"https://www.wikidata.org/wiki/Q416601","display_name":"Androgen receptor","level":4,"score":0.25375786423683167},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.24560484290122986}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2017.35.15_suppl.5071","doi":"https://doi.org/10.1200/jco.2017.35.15_suppl.5071","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2017.35.15_suppl.5071","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","score":0.8100000023841858,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2479291038","https://openalex.org/W2602334924","https://openalex.org/W2741897432","https://openalex.org/W4282938890","https://openalex.org/W2889668110","https://openalex.org/W4401280037","https://openalex.org/W2889946284","https://openalex.org/W2595856813","https://openalex.org/W2598487689","https://openalex.org/W2770625587"],"abstract_inverted_index":{"5071":[0],"Background:":[1],"An":[2],"urgent":[3],"need":[4],"exists":[5],"for":[6,142,290,295,313,319,353],"new":[7],"therapies":[8],"after":[9,81],"progression":[10],"(PD)":[11],"onAA":[12],"and":[13,125,133,140,177,201,213,228,255,293,307,317,338],"enzalutamide":[14],"(ENZ).":[15],"Increased":[16],"PR":[17,39,143],"expression":[18],"or":[19,197,244],"progesterone-activating":[20],"AR":[21,29,63,146,249,258,280,291,296,314,320,351,366],"mutations":[22],"have":[23],"been":[24],"associated":[25],"with":[26,41,87,105,109,231,267,274,341,360],"resistance":[27],"to":[28,33,58,211,218],"targeting.":[30],"We":[31],"aimed":[32,57],"test":[34],"ONA,":[35],"a":[36,51,70,93,239,369],"type":[37],"I":[38],"antagonist":[40],"clinical":[42,76],"activity":[43,127],"in":[44,47,78,113,221,252,271,334,339,347],"PRpos":[45],"cancers,":[46],"AA/enz-resistant":[48],"CRPC.":[49],"In":[50],"prospectively":[52],"defined":[53],"exploratory":[54],"analysis,":[55],"we":[56],"report":[59],"outcome":[60],"by":[61,129,349],"plasma":[62,226,253,365],"status":[64,352],"(":[65],"pAR).":[66],"Methods:":[67],"This":[68],"was":[69,102,147,287,310,344],"multi-institution,":[71],"open":[72],"label":[73],"phase":[74],"I/II":[75],"trial":[77,374],"pts":[79,114,157,179,236,273,362],"progressing":[80,115],"ENZ/AA.":[82],"Pts":[83],"were":[84,121,136,194,264,279,364],"first":[85],"treated":[86],"single":[88],"agent":[89],"(SA)":[90],"ONA":[91,98,160,186,191,223,269,286,331,355],"using":[92,149],"randomised":[94],"dose":[95],"escalation":[96],"design.":[97],"at":[99],"2":[100,272],"doses":[101],"then":[103],"combined":[104],"AA":[106],"(1000mg":[107],"od":[108],"pred":[110],"5mg":[111],"bid)":[112],"on":[116,284,308,357],"AA.":[117,232,342],"The":[118,282],"primary":[119],"end-points":[120],"safety,":[122],"pharmacokinetics":[123],"(PK)":[124],"anti-tumor":[126],"split":[128],"p":[130,145,350],"AR.":[131],"Archival":[132],"metastatic":[134],"biopsies":[135],"collected":[137],"when":[138],"possible":[139],"tested":[141],"status.":[144],"studied":[148],"previous":[150],"methods":[151],"(Romanel":[152],"STM":[153],"2015).":[154],"Results:":[155],"21":[156],"received":[158,180],"SA":[159,222,268,285,337,354],"(5":[161,183],"=":[162,165,168,171,174,184,189],"10mg/":[163],"5":[164],"20mg/":[166],"4":[167,170],"30mg/":[169],"40mg":[172],"/3":[173],"50mg":[175,190],"BID)":[176],"15":[178,237],"ONA-AA":[181],"combination":[182,275,309,340,359],"30mg":[185],"BID,":[187],"10":[188],"BID).":[192],"There":[193,343],"not":[195,265],"DLTs":[196],"significant":[198],"LFT":[199],"abnormalities":[200],"no":[202,207,214,229,345],"G3/4":[203],"adverse":[204],"events":[205],"(AE),":[206],"treatment":[208],"discontinuations":[209],"due":[210],"AEs":[212],"SAEs":[215],"considered":[216],"related":[217],"ONA.":[219],"PK":[220],"observed":[224,266],"active":[225],"concentrations":[227],"interaction":[230],"Of":[233],"32":[234],"evaluated":[235],"had":[238,257,368],"2105T":[240],">":[241,246],"A":[242],"(p.L702H)":[243],"2632A":[245],"G":[247],"(p.T878A)":[248],"mutation":[250],"detected":[251],"pre-treatment":[254],"1":[256],"copy":[259],"number":[260],"gain.":[261],"PSA":[262],"declines":[263],"but":[270,356],"(-30%,":[276],"-7%)":[277],"who":[278,363],"normal.":[281],"rPFS":[283,348],"2.8":[288],"months":[289,312],"normal":[292,315,367],"2.6":[294],"aberrant":[297,321],"(Hazard":[298],"ratio":[299],"(HR)":[300],"1.41;":[301],"95%":[302],"CI,":[303],"0.62-3.72;":[304],"P":[305,327],"0.48)":[306],"4.4":[311],"(8/15)":[316],"2.2":[318],"(7/15)":[322],"(HR":[323],"6.08;":[324],"95%CI,":[325],"6.32-221.9;":[326],"<":[328],"0.001).":[329],"Conclusions:":[330],"is":[332],"safe":[333],"CRPC":[335],"as":[336],"difference":[346],"the":[358],"AA,":[361],"significantly":[370],"longer":[371],"rPFS.":[372],"Clinical":[373],"information:":[375],"NCT02049190.":[376]},"counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2018-09-27T00:00:00"}